Blocking the PD-1/PD-L1 pathway has been shown to restore the activity of exhausted virus-specific CD8 + T cells, resulting in regulated chronic HIV infection [44] and enhanced anti-cancer immunity [45]. The gene discussed is CD8A; the disease is HIV infectious disease.